Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Mouth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01533181
What this trial is testing

Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Study completedNCT00006471
What this trial is testing

Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Ended earlyNCT00003223
What this trial is testing

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 5
Not applicableStudy completedNCT04045561
What this trial is testing

Development of a Standardized Reference Guide for Tuning Adherence to Dispense During a Initial Pharmaceutical Consulting (CP ) to the Patient With Multiple Myeloma Oral Chemotherapy Primocure

Who this might be right for
Multiple Myeloma
Centre Hospitalier Universitaire de Nīmes 10
Post-approval studies (Phase 4)Study completedNCT02581423
What this trial is testing

Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 63
Early research (Phase 1)Study completedNCT04771390
What this trial is testing

Study to Compare How the Body Absorbs, Distributes and Excretes the Drug Selitrectinib (BAY2731954) Given as Two Different Tablet Formulations or as Liquid Formulations Including the Effect of Food on the Absorption, Distribution or Excretion of the Different Formulations in Healthy Participants

Who this might be right for
Solid Tumors Harboring NTRK Fusion
Bayer 52
Testing effectiveness (Phase 2)Study completedNCT00248560
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Barbara Ann Karmanos Cancer Institute 36
Post-approval studies (Phase 4)UnknownNCT01588873
What this trial is testing

Contraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary Syndrome

Who this might be right for
Adverse Effect of Oral Contraceptives, Sequela
University of Oulu 42
Not applicableAvailableNCT06761976
What this trial is testing

Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation

Who this might be right for
Advanced Non-small Cell Lung CancerCancer
Bayer
Not applicableStudy completedNCT07185542
What this trial is testing

Function-Preserving Surgery for Parotid Tumors: Intracapsular Versus Superficial Parotidectomy; A Randomized Clinical Trial.

Who this might be right for
Parotid TumorsParotidectomy
Al-Azhar University 120
Early research (Phase 1)Study completedNCT04126707
What this trial is testing

The Absorption, Metabolism and Excretion of [14C] HQP1351 in Humans

Who this might be right for
Chronic Myeloid Leukemia (CML)
Ascentage Pharma Group Inc. 6
Large-scale testing (Phase 3)Study completedNCT02923258
What this trial is testing

Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 224
Testing effectiveness (Phase 2)Study completedNCT01125800
What this trial is testing

A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB

Who this might be right for
MedulloblastomaRhabdomyosarcomaNeuroblastoma+3 more
Novartis Pharmaceuticals 76
Early research (Phase 1)UnknownNCT05768321
What this trial is testing

Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation

Who this might be right for
Advanced Solid Tumors
GenEros Biopharma Hangzhou Ltd 70
Early research (Phase 1)Study completedNCT03301207
What this trial is testing

Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell Malignancy

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen Research & Development, LLC 25
Not applicableStudy completedNCT00483821
What this trial is testing

A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 165
Early research (Phase 1)Study completedNCT00390052
What this trial is testing

3-AP in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT02966652
What this trial is testing

Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism

Who this might be right for
Male Hypogonadism
Neurocrine UK Limited 25
Not applicableStudy completedNCT04915599
What this trial is testing

Feasibility and Patient Reported Tolerance of Cryotherapy With the Cooral ® Mouth Cooling Device [MCD) in Patients Undergoing Radiation Therapy

Who this might be right for
Oral Mucositis
University Hospital, Basel, Switzerland 10
Early research (Phase 1)Study completedNCT02594384
What this trial is testing

A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic
OrphAI Therapeutics 62
Next Page